Restless legs syndrome: Diagnostic time-savers, Tx tips

Journal of Family Practice

Volumn 58, Issue 8, 2009, Pages 415-423

  Moyer, Darlene E ^a,c   Javier, Zayas Bazan ^a   Reese, Gary ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Scottsdale Headache Center   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CODEINE; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; GABAPENTIN; LITHIUM; NEUROLEPTIC AGENT; OPIATE; PLACEBO; PRAMIPEXOLE; ROPINIROLE; VALPROIC ACID;

ARTICLE; BEDTIME DOSAGE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DAYTIME SOMNOLENCE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; FATIGUE; FERRITIN BLOOD LEVEL; HEADACHE; HUMAN; IRON DEFICIENCY; IRON THERAPY; KIDNEY FAILURE; LEG MOVEMENT; MALAISE; MENTAL PERFORMANCE; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATIENT CARE; PHYSICAL ACTIVITY; PREGNANCY; RESTLESS LEGS SYNDROME; SEDATION; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOMNOLENCE; VOMITING; XEROSTOMIA;

DECISION TREES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FERRITINS; HUMANS; MIDDLE AGED; NEUROTRANSMITTER AGENTS; RESTLESS LEGS SYNDROME; RISK FACTORS;

EID: 68349085859     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Karroum E, Konofal E, Arnulf I. Restless-legs syndrome. Rev Neurol. 2008;164:701-721.
2. Vergne-Salle P, Coyral D, Dufauret K, et al. Is restless legs syndrome underrecognized? Current management. Joint Bone Spine. 2006;73:369-373. (Pubitemid 44038430)
3. Fulda S, Wetter TC. Dopamine agonists for the treatment of restless legs syndrome. Expert Opin Pharmacother. 2005;6:2655-2666. (Pubitemid 41824380)
4. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286-1292. (Pubitemid 40989594)
5. Conti C, de Oliveira MM, Andriolo RB, et al. Levodopa for idiopathic restless legs syndrome: evidence-based review. Mov Disord. 2007;22:1943-1951. (Pubitemid 350134209)
6. Restless Legs Syndrome Foundation. RLS Medical Bulletin. 2005. Available at: http://www.irlssg.org/RLSMB2005pf.pdf. Accessed July 9, 2009.
7. Ryan M, Slevin J. Restless legs syndrome. Am J Health Syst Pharm. 2006;63:1599-1612.
8. Oertel W, Trenkwalder C, Zucconi M, et al. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Mov Disord. 2007;22(suppl 18):S466-S475.
9. Thorpy M. New paradigms in the treatment of restless legs syndrome. Neurology. 2005;64(12 suppl 3):S28-S33. (Pubitemid 40875372)
10. Winkelman J. A better future for patients with restless legs syndrome. Am J Med. 2007;120(1 suppl 1):S28-S29. (Pubitemid 46014147)
11. Chahine L, Chemali Z. Restless legs syndrome: a review. CNS Spectr. 2006;11:511-520.
12. Johnson E. Omnibus Sleep in America poll. National Sleep Foundation. 1998.
13. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Neurology. 2000;54:1064-1068.
14. Garcia-Borreguero D. Time to REST: epidemiology and burden. Eur J Neurol. 2006;13(suppl 3):S15-S20.
15. Schapira A. RLS patients: who are they? Eur J Neurol. 2006;13(suppl 3):S2-S7.
16. Benes H, Walters AS, Allen RP, et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22(suppl 18):S401-S408.
17. Hening W, Allen R, Tenzer P, et al. Restless legs syndrome: demographics, presentation and differential diagnosis. Geriatrics. 2007;62:26-29. (Pubitemid 47429276)
18. O'Keefe ST, Gavin K, Lavan JN. Iron status and restless legs in the elderly. Age Ageing. 1994;23:200-203. (Pubitemid 24158288)
19. Sun ER, Chen CA, Ho G, et al. Iron and the restless legs syndrome. Sleep. 1998;21:371-377.
20. Akpinar S. Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol. 1987;10:69-79. (Pubitemid 17005659)
21. Becker P, Jamieson A, Brown D. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep. 1993;16:713-716. (Pubitemid 24054962)
22. Von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs. A 2 year follow-up. Arch Neurol. 1990;47:1223-1224.
23. Bertoni JM, Arlette JP, Fernandez HH, et al. Epidemiologic association of Parkinson's disease and melanoma. Mov Disord. 2006;21(suppl 15):S610.
24. Fiala K, Whetteckey J, Manyam B. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? Parkinsonism Relat Disord. 2003;9:321-327.
25. Montagna P. The treatment of restless legs syndrome. Neurol Sci. 2007;28(suppl 1):S61-S66. (Pubitemid 46152130)
26. Kushida C. Clinical presentation, diagnosis and quality of life issues in restless legs syndrome. Am J Med. 2007;120(1 suppl 1):S4-S12. (Pubitemid 46014144)
27. Baker W, White C, Coleman C. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med. 2008;6:253-262. (Pubitemid 351716785)
28. Fulda S, Wetter T. Emerging drugs for restless legs syndrome. Expert Opin Emerg Drugs. 2005;10:527-552. (Pubitemid 41176286)
29. Walters A, Wagner M, Hening W, et al. Successful treatment of idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;16:327-332. (Pubitemid 23176289)
30. Walters A, Winkelman J, Trenkwalder C, et al. Long term follow-up on restless legs syndrome patients treated with opioids. Mov Disord. 2001;16:1105-1109. (Pubitemid 36041223)
31. Boghen D, Lamothe L, Elie R. The treatment of restless legs syndrome with clonazepam: a prospective controlled trial. Can J Neurol Sci. 1986;13:245-247.
32. Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry. 1987;50:1679-1681. (Pubitemid 18096681)
33. Ferni-Strambi L. RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Med. 2007;8(suppl 2):S3-S6.